UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 59

Sortiert nach

The Nucleocapsid Protein of SARS-CoV-2: a Target for Vaccine Development

Journal of virology, 2020-06, Vol.94 (13)

2020

Volltextzugriff (PDF)

The anti-tubercular activity of simvastatin is mediated by cholesterol-driven autophagy via the AMPK-mTORC1-TFEB axis

Journal of lipid research, 2020-12, Vol.61 (12), p.1617-1628

2020

Volltextzugriff (PDF)

A Mycobacterium tuberculosis sigma factor network responds to cell-envelope damage by the promising anti-mycobacterial thioridazine

PloS one, 2010-04, Vol.5 (4), p.e10069

2010

Volltextzugriff (PDF)

Transcriptional reprogramming in nonhuman primate (rhesus macaque) tuberculosis granulomas

PloS one, 2010-08, Vol.5 (8), p.e12266-e12266

2010

Volltextzugriff (PDF)

Are There Sex-Specific Differences in Response to Adjunctive Host-Directed Therapies for Tuberculosis?

Frontiers in immunology, 2020-07, Vol.11, p.1465-1465

2020

Volltextzugriff (PDF)

Genetic Requirements for the Survival of Tubercle Bacilli in Primates

The Journal of infectious diseases, 2010-06, Vol.201 (11), p.1743-1752

2010

Volltextzugriff (PDF)

The stress-response factor SigH modulates the interaction between Mycobacterium tuberculosis and host phagocytes

PloS one, 2012-01, Vol.7 (1), p.e28958-e28958

2012

Volltextzugriff (PDF)

Latent tuberculosis infection: myths, models, and molecular mechanisms

Microbiology and molecular biology reviews, 2014-09, Vol.78 (3), p.343-371

2014

Volltextzugriff (PDF)

Commentary: Rifabutin Resistance Associated with Double Mutations in rpoB Gene in Mycobacterium tuberculosis Isolates

Frontiers in microbiology, 2017-11, Vol.8, p.2274-2274

2017

Volltextzugriff (PDF)

Antibiotic Treatment Shapes the Antigenic Environment During Chronic TB Infection, Offering Novel Targets for Therapeutic Vaccination

Frontiers in immunology, 2020-04, Vol.11, p.680-680

2020

Volltextzugriff (PDF)

Can the duration of tuberculosis treatment be shortened with higher dosages of rifampicin?

Frontiers in microbiology, 2015-10, Vol.6, p.1117-1117

2015

Volltextzugriff (PDF)

Potent Rifamycin-Sparing Regimen Cures Guinea Pig Tuberculosis as Rapidly as the Standard Regimen

Antimicrobial Agents and Chemotherapy, 2013-08, Vol.57 (8), p.3910-3916

2013

Volltextzugriff (PDF)

Mycobacterium tuberculosis MT2816 Encodes a Key Stress-Response Regulator

The Journal of infectious diseases, 2010-09, Vol.202 (6), p.943-953

2010

Volltextzugriff (PDF)

Rifapentine Is Not More Active than Rifampin against Chronic Tuberculosis in Guinea Pigs

Antimicrobial Agents and Chemotherapy, 2012-07, Vol.56 (7), p.3726-3731

2012

Volltextzugriff (PDF)

Preliminary Pharmacokinetic Study of Repeated Doses of Rifampin and Rifapentine in Guinea Pigs

Antimicrobial Agents and Chemotherapy, 2013-03, Vol.57 (3), p.1535-1537

2013

Volltextzugriff (PDF)

Systems biology-based identification of Mycobacterium tuberculosis persistence genes in mouse lungs

mBio, 2014-02, Vol.5 (1)

2014

Volltextzugriff (PDF)

Host-Mediated Bioactivation of Pyrazinamide: Implications for Efficacy, Resistance, and Therapeutic Alternatives

ACS infectious diseases, 2015-05, Vol.1 (5), p.203-214

2015

Volltextzugriff (PDF)

Accelerating Drug Development through Repurposed FDA-Approved Drugs for COVID-19: Speed Is Important, Not Haste

Antimicrobial agents and chemotherapy, 2020-07, Vol.64 (8)

2020

Volltextzugriff (PDF)

Metformin Adjunctive Therapy Does Not Improve the Sterilizing Activity of the First-Line Antitubercular Regimen in Mice

Antimicrobial agents and chemotherapy, 2017-08, Vol.61 (8)

2017

Volltextzugriff (PDF)

Statin adjunctive therapy shortens the duration of TB treatment in mice

Journal of antimicrobial chemotherapy, 2016-06, Vol.71 (6), p.1570-1577

2016

Volltextzugriff (PDF)

Reply to Hu et al: Could there be detrimental effects of statin adjunctive TB therapy on immune responses?

The Journal of infectious diseases, 2020-06, Vol.222 (2), p.336-337

2020

Volltextzugriff (PDF)

Aerosolized Gentamicin Reduces the Burden of Tuberculosis in a Murine Model

Antimicrobial Agents and Chemotherapy, 2012-02, Vol.56 (2), p.883-886

2012

Volltextzugriff (PDF)

Remembering the Host in Tuberculosis Drug Development

The Journal of infectious diseases, 2019-04, Vol.219 (10), p.1518-1524

2019

Volltextzugriff (PDF)

Characterization of a Novel Necrotic Granuloma Model of Latent Tuberculosis Infection and Reactivation in Mice

The American journal of pathology, 2014-07, Vol.184 (7), p.2045-2055

2014

Volltextzugriff (PDF)

1 – 25 von 59

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(52)
Mit Volltextzugriff
(58)

Publikationsform

Artikel
(56)
Buchkapitel
(3)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(46)
Life Sciences & Biomedicine
(42)
Animals
(34)
Microbiology
(27)
Mice
(21)
Mycobacterium Tuberculosis
(21)
Female
(18)
Humans
(18)
Mycobacterium Tuberculosis - Drug Effects
(18)
Pharmacology & Pharmacy
(18)
Tuberculosis
(16)
Infectious Diseases
(14)
Antitubercular Agents - Therapeutic Use
(13)
Immunology
(12)
Tuberculosis - Drug Therapy
(12)
Disease Models, Animal
(10)
Antitubercular Agents
(8)
Biological And Medical Sciences
(8)
Lung - Microbiology
(8)
Male
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The Nucleocapsid Protein of SARS-CoV-2: a Target for Vaccine Development

The anti-tubercular activity of simvastatin is mediated by cholesterol-driven autophagy via the AMPK-mTORC1-TFEB axis

A Mycobacterium tuberculosis sigma factor network responds to cell-envelope damage by the promising anti-mycobacterial thioridazine

Transcriptional reprogramming in nonhuman primate (rhesus macaque) tuberculosis granulomas

Are There Sex-Specific Differences in Response to Adjunctive Host-Directed Therapies for Tuberculosis?

Genetic Requirements for the Survival of Tubercle Bacilli in Primates

The stress-response factor SigH modulates the interaction between Mycobacterium tuberculosis and host phagocytes

Latent tuberculosis infection: myths, models, and molecular mechanisms

Commentary: Rifabutin Resistance Associated with Double Mutations in rpoB Gene in Mycobacterium tuberculosis Isolates

Antibiotic Treatment Shapes the Antigenic Environment During Chronic TB Infection, Offering Novel Targets for Therapeutic Vaccination

Can the duration of tuberculosis treatment be shortened with higher dosages of rifampicin?

Potent Rifamycin-Sparing Regimen Cures Guinea Pig Tuberculosis as Rapidly as the Standard Regimen

Mycobacterium tuberculosis MT2816 Encodes a Key Stress-Response Regulator

Rifapentine Is Not More Active than Rifampin against Chronic Tuberculosis in Guinea Pigs

Preliminary Pharmacokinetic Study of Repeated Doses of Rifampin and Rifapentine in Guinea Pigs

Systems biology-based identification of Mycobacterium tuberculosis persistence genes in mouse lungs

Host-Mediated Bioactivation of Pyrazinamide: Implications for Efficacy, Resistance, and Therapeutic Alternatives

Accelerating Drug Development through Repurposed FDA-Approved Drugs for COVID-19: Speed Is Important, Not Haste

Metformin Adjunctive Therapy Does Not Improve the Sterilizing Activity of the First-Line Antitubercular Regimen in Mice

Statin adjunctive therapy shortens the duration of TB treatment in mice

Reply to Hu et al: Could there be detrimental effects of statin adjunctive TB therapy on immune responses?

Development of a Novel Lead that Targets M. tuberculosis Polyketide Synthase 13

Aerosolized Gentamicin Reduces the Burden of Tuberculosis in a Murine Model

Remembering the Host in Tuberculosis Drug Development

Characterization of a Novel Necrotic Granuloma Model of Latent Tuberculosis Infection and Reactivation in Mice

Suchergebnisse filtern